Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inari Medical, Inc. (NARI)
NASDAQ:NARI
Inari Medical (NARI) Stock Price & Analysis
283 Followers
NARI Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$39.90 - $71.85
Previous Close$42.14
Volume817.35K
Average Volume (3M)1.22M
Market Cap
$2.48B
Enterprise Value$2.12B
Total Cash (Recent Filing)$351.30M
Total Debt (Recent Filing)$32.26M
Price to Earnings (P/E)-1321.0
Beta0.95
Next Earnings
May 01, 2024EPS Estimate
-$0.16Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding57,960,555
10 Day Avg. Volume2,356,022
30 Day Avg. Volume1,215,020
Standard Deviation0.13
R-Squared0.11
Alpha-0.00144
Financial Highlights & Ratios
Price to Book (P/B)24.50
Price to Sales (P/S)6.37
Price to Cash Flow (P/CF)49.90
P/FCF Ratio49.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.52
Enterprise Value/Gross Profit6.26
Enterprise Value/Ebitda191.59
Forecast
1Y Price Target
$73.00Price Target Upside70.80% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Inari Medical News
Ownership Overview
22.78% Insiders
37.99% Mutual Funds
37.18% Other Institutional Investors
2.05% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
NARI FAQ
What was Inari Medical, Inc.’s price range in the past 12 months?
Inari Medical, Inc. lowest stock price was $39.90 and its highest was $71.85 in the past 12 months.
What is Inari Medical, Inc.’s market cap?
Currently, no data Available
When is Inari Medical, Inc.’s upcoming earnings report date?
Inari Medical, Inc.’s upcoming earnings report date is May 01, 2024 which is in 14 days.
How were Inari Medical, Inc.’s earnings last quarter?
Inari Medical, Inc. released its earnings results on Feb 28, 2024. The company reported -$0.08 earnings per share for the quarter, missing the consensus estimate of $0.006 by -$0.086.
Is Inari Medical, Inc. overvalued?
According to Wall Street analysts Inari Medical, Inc.’s price is currently Undervalued.
Does Inari Medical, Inc. pay dividends?
Inari Medical, Inc. does not currently pay dividends.
What is Inari Medical, Inc.’s EPS estimate?
Inari Medical, Inc.’s EPS estimate is -$0.16.
How many shares outstanding does Inari Medical, Inc. have?
Inari Medical, Inc. has 57,960,556 shares outstanding.
What happened to Inari Medical, Inc.’s price movement after its last earnings report?
Inari Medical, Inc. reported an EPS of -$0.08 in its last earnings report, missing expectations of $0.006. Following the earnings report the stock price went down -20.838%.
Which hedge fund is a major shareholder of Inari Medical, Inc.?
Among the largest hedge funds holding Inari Medical, Inc.’s share is Slate Path Capital LP. It holds Inari Medical, Inc.’s shares valued at 27M.
---
Inari Medical Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$73.00 (70.80% Upside)
$73.00 (70.80% Upside)
Blogger Sentiment
Bullish
NARI Sentiment 83%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 373.3K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.8%
Last 30 Days ▼ 6.0%
Last 30 Days ▼ 6.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-34.43%
12-Months-Change
Fundamentals
Return on Equity
-0.37%
Trailing 12-Months
Asset Growth
33.74%
Trailing 12-Months
Company Description
Inari Medical, Inc.
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from venous diseases. Its product portfolio includes ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTreiver product is used for the treatment of pulmonary embolism. Geographically, the company has its presence across the United States.
---
NARI Earnings Call
Q4 2024
0:00 / 0:00
---
NARI Stock 12 Months Forecast
Average Price Target
$73.00
▲(70.80% Upside)
Technical Analysis
Best Analysts Covering NARI
1 Year
1 Year Success Rate
5/17 ratings generated profit
1 Year Average Return
-3.92%
reiterated a buy rating 2 months ago
Copying William Plovanic's trades and holding each position for 1 Year would result in 29.41% of your transactions generating a profit, with an average return of -3.92% per trade.
---